{
    "data": [
        {
            "title": "Lear Investment Management wins Zephyr/PSN \"Manager of the Decade\" award, showcasing exceptional performance.",
            "id": "63f28e11-f863-43cc-944f-d7c19c0472df",
            "description": "In Dallas on February 27, 2026, Lear Investment Management, known for its strategic approach and flexibility, has been honored with the prestigious title of Zephyr/PSN Manager of the Decade. This award acknowledges the firm's exceptional performance in the financial market, particularly in its Global Vigilance Conservative strategy.",
            "link": "https://www.markets.news/headlines/63f28e11-f863-43cc-944f-d7c19c0472df",
            "pub_date": "2026-02-28 02:06:50",
            "source": "unusualwhales",
            "kind": 1,
            "language": "en"
        },
        {
            "title": "",
            "id": "54d38bd6-4e7b-4817-bc9f-942087842d61",
            "description": "TRUMP: WE'RE HAVING TREMENDOUS LUCK WITH OIL",
            "link": "https://www.markets.news/headlines/54d38bd6-4e7b-4817-bc9f-942087842d61",
            "pub_date": "2026-02-28 02:08:04",
            "source": "unusualwhales",
            "kind": 1,
            "language": "en"
        },
        {
            "title": "McLean & Company announces Shawn Kanungo as keynote for Signature 2026 HR Conference in Las Vegas on October 4-6, 2026.",
            "id": "eac1da3f-349b-4eb3-a90a-a2f33c33dd8a",
            "description": "Renowned innovation strategist and bestselling author Shawn Kanungo has been selected as the keynote speaker for Signature 2026, the premier HR conference organized by McLean & Company. The event is scheduled to be held from October 4 to 6, 2026, at the Virgin Hotels Las Vegas. Kanungo, a globally recognized figure, is known for his dynamic presentations and expertise in the field of innovation. This significant announcement highlights the prestigious lineup of speakers and events planned for the conference, which is expected to draw a large audience of professionals and industry experts.",
            "link": "https://www.markets.news/headlines/eac1da3f-349b-4eb3-a90a-a2f33c33dd8a",
            "pub_date": "2026-02-28 02:08:52",
            "source": "unusualwhales",
            "kind": 1,
            "language": "en"
        },
        {
            "title": "",
            "id": "2c14aa1b-f59f-4143-b249-0a5d70edf052",
            "description": "TRUMP: WE'LL SEE WHAT HAPPENS WITH IRAN, WILL ALL WORK OUT WELL",
            "link": "https://www.markets.news/headlines/2c14aa1b-f59f-4143-b249-0a5d70edf052",
            "pub_date": "2026-02-28 02:09:11",
            "source": "unusualwhales",
            "kind": 1,
            "language": "en"
        },
        {
            "title": "",
            "id": "4a9215df-810a-418f-be4e-28d37d6663dc",
            "description": "TRUMP: PRICES OF GASOLINE ARE COMING WAY DOWN",
            "link": "https://www.markets.news/headlines/4a9215df-810a-418f-be4e-28d37d6663dc",
            "pub_date": "2026-02-28 02:09:17",
            "source": "unusualwhales",
            "kind": 1,
            "language": "en"
        },
        {
            "title": "Surgery Partners set to release EPS of $0.29 on 2026-03-02, stock trading at $15.37, down 34.79% in past year.",
            "id": "620c5e3c-e21c-4363-bfa3-fc57943a7c42",
            "description": "Surgery Partners (NASDAQ: SGRY) is set to release its quarterly earnings, with analysts predicting an EPS of $0.29. Investors are hoping for positive news that exceeds estimates and provides guidance for the next quarter. Past earnings show a miss of $0.01 in the previous quarter, resulting in a 1.81% drop in share price. Shares were trading at $15.37 on February 26, with a 52-week decrease of 34.79%. The company's performance and stock prices can be significantly impacted by future projections rather than just historical data. For more details, visit Benzinga.com.",
            "link": "https://www.markets.news/headlines/620c5e3c-e21c-4363-bfa3-fc57943a7c42",
            "pub_date": "2026-02-28 02:04:49",
            "source": "unusualwhales",
            "kind": 1,
            "language": "en"
        },
        {
            "title": "UroGen Pharma to report earnings ($-0.57 EPS) on Monday. Investors anticipate positive guidance. Market reaction driven by guidance.",
            "id": "6c67561f-92e3-4073-801e-4be0b2adaa3f",
            "description": "UroGen Pharma, listed as URGN on NASDAQ, is gearing up to release its latest quarterly earnings report on Monday, March 2, 2026. Analysts are predicting that the company will post an earnings per share (EPS) of -$0.57. There is considerable excitement among investors leading up to this announcement, as there is hope for UroGen Pharma to exceed these expectations and provide a positive outlook for the upcoming quarter. It is crucial for new investors to grasp that while earnings are significant, market response is often heavily influenced by future guidance. In the previous quarter, UroGen Pharma outperformed EPS estimates by $0.01. For more detailed information, the full story can be found on Benzinga.com.",
            "link": "https://www.markets.news/headlines/6c67561f-92e3-4073-801e-4be0b2adaa3f",
            "pub_date": "2026-02-28 02:04:52",
            "source": "unusualwhales",
            "kind": 1,
            "language": "en"
        },
        {
            "title": "Nuvation Bio (NYSE: NUVB) to release Q1 earnings with estimated EPS of $-0.07. Stock trading at $5.8, up 218.96% in 52 weeks.",
            "id": "1f072972-344b-4d54-a149-02f8e4075fb1",
            "description": "Nuvation Bio is set to announce its quarterly earnings on March 2, with analysts predicting an EPS of -$0.07. Investors are hopeful for positive news and guidance for the next quarter. In the last quarter, the company missed EPS estimates by $0.00, resulting in a 6.58% share price drop. Over the past year, Nuvation Bio's stock has seen a 218.96% increase, with shares currently trading at $5.80. Stock prices can be influenced by future projections rather than just past performance, making it important for investors to consider both.",
            "link": "https://www.markets.news/headlines/1f072972-344b-4d54-a149-02f8e4075fb1",
            "pub_date": "2026-02-28 02:04:54",
            "source": "unusualwhales",
            "kind": 1,
            "language": "en"
        },
        {
            "title": "Zymeworks to release earnings with an expected EPS of $-0.33 on 2026-03-02. Past performance impacted stock price. Up 81.32% in 52 weeks.",
            "id": "15ce1f56-15c0-4576-a556-7aa09c835efc",
            "description": "Zymeworks (NASDAQ: ZYME) is set to release its quarterly earnings on Monday, March 2, 2026. Analysts anticipate an earnings per share (EPS) of $-0.33. Investors are eager for the announcement, hoping to see results surpassing estimates and receiving positive guidance for the next quarter. In the previous release, Zymeworks exceeded EPS by $0.05, leading to an 8.04% drop in share price. The stock was trading at $23.81 on February 26, up 81.32% over the last 52 weeks. It is crucial for new investors to understand that while earnings performance matters, market reactions are often guided by future forecasts. For more information, refer to the full story on Benzinga.com.",
            "link": "https://www.markets.news/headlines/15ce1f56-15c0-4576-a556-7aa09c835efc",
            "pub_date": "2026-02-28 02:04:56",
            "source": "unusualwhales",
            "kind": 1,
            "language": "en"
        },
        {
            "title": "Kosmos Energy (NYSE: KOS) to report EPS of $-0.09 on 2026-03-02. Past misses led to share price drops, trading at $2.2.",
            "id": "ffcacb49-3612-48c2-a174-41dffbab7262",
            "description": "Kosmos Energy (NYSE: KOS) will release its latest quarterly earnings report on March 2, 2026. Analysts predict an EPS of $-0.09. Investors are hopeful for positive news and guidance. Last quarter, the company missed EPS by $0.05, resulting in a 0.0% drop in share price the next day. Past performance includes missing EPS estimates in previous quarters. As of February 26, shares were trading at $2.2, with a 10.55% decrease in the last 52 weeks. Future projections heavily impact stock prices alongside past performance. Investors should watch closely.",
            "link": "https://www.markets.news/headlines/ffcacb49-3612-48c2-a174-41dffbab7262",
            "pub_date": "2026-02-28 02:05:00",
            "source": "unusualwhales",
            "kind": 1,
            "language": "en"
        },
        {
            "title": "Quanterix (NASDAQ: QTRX) to report EPS of $-0.40 on March 2, with past quarter performance leading to 2.34% stock price drop. Stock at $6.72, down 7.69% in past year. Eager anticipation for surpassing estimates and positive guidance for next quarter.",
            "id": "b2abcd45-a40e-4378-a3f2-01708bc76f6c",
            "description": "Quanterix (QTRX) is set to release its quarterly earnings on March 2, 2026. Analysts predict an EPS of $-0.40. Investors hope for results surpassing estimates and positive guidance. Future projections heavily impact stock prices. Last quarter, Quanterix exceeded EPS by $0.06, leading to a 2.34% share price drop the next day. Previous quarters reflect mixed results. As of February 26, shares traded at $6.72, down 7.69% in the past year. Long-term investors may be concerned. For more details, visit Benzinga.com.",
            "link": "https://www.markets.news/headlines/b2abcd45-a40e-4378-a3f2-01708bc76f6c",
            "pub_date": "2026-02-28 02:05:02",
            "source": "unusualwhales",
            "kind": 1,
            "language": "en"
        },
        {
            "title": "Vitesse Energy to report earnings on 3/2, with EPS estimate of $0.15. Previous EPS beat led to 2.93% stock drop. Shares at $19.84 as of 2/26.",
            "id": "77723e5a-f835-4959-83e9-553433102f00",
            "description": "Vitesse Energy (NYSE: VTS) is set to release its quarterly earnings report on March 2, 2026. Analysts are expecting an earnings per share (EPS) of $0.15. The company previously beat EPS by $0.01 in the last earnings release, resulting in a 2.93% drop in share price. Vitesse Energy's stock was trading at $19.84 as of February 26. It's important for investors to focus not just on earnings beats or misses, but also on the company's guidance for the next quarter, as this often impacts stock prices significantly. In past quarters, earnings estimates and actual EPS figures have varied, leading to fluctuations in share prices. New investors should keep an eye on the upcoming earnings release for potential insights into the company's future performance and growth prospects.",
            "link": "https://www.markets.news/headlines/77723e5a-f835-4959-83e9-553433102f00",
            "pub_date": "2026-02-28 02:05:05",
            "source": "unusualwhales",
            "kind": 1,
            "language": "en"
        },
        {
            "title": "",
            "id": "5aef26d2-f67c-43ad-8e0a-6fdfa1b859d0",
            "description": "TRUMP: I SPOKE WITH PRESIDENT PUTIN, WANT WAR TO END",
            "link": "https://www.markets.news/headlines/5aef26d2-f67c-43ad-8e0a-6fdfa1b859d0",
            "pub_date": "2026-02-28 02:05:23",
            "source": "unusualwhales",
            "kind": 1,
            "language": "en"
        },
        {
            "title": "Intact Technology named 2026 ServiceNow U.S. Federal Partner of the Year and Worldwide AI Customer Value Partner of the Year.",
            "id": "49502971-788a-45f3-b26d-cba529060348",
            "description": "Intact Technology, a renowned ServiceNow Partner specializing in Federal and highly regulated enterprise settings, has been honored with two prestigious awards in the 2026 ServiceNow Partner Awards. The company has been named the U.S. Federal Government Partner of the Year for the Americas and the AI Customer Value Partner of the World. This recognition highlights Intact's expertise in managing intricate ServiceNow projects within the Federal Government, showcasing its commitment to excellence in this field.",
            "link": "https://www.markets.news/headlines/49502971-788a-45f3-b26d-cba529060348",
            "pub_date": "2026-02-28 02:05:51",
            "source": "unusualwhales",
            "kind": 1,
            "language": "en"
        },
        {
            "title": "ValGenesis to exhibit at BioProcessing Summit Europe 2026 in Barcelona, featuring Global Leader in digital validation lifecycle management.",
            "id": "3016abb6-bb55-4ec2-a6a3-ca9e7e8909a5",
            "description": "ValGenesis Inc., a top digital validation lifecycle management firm, is set to present its Process Lifecycle Suite at the BioProcessing Summit Europe 2026 in Barcelona from March 10-12. This event is a key gathering for bioprocessing leaders, scientists, and industry influencers driving modern biomanufacturing. Noteworthy attendees include numerous pharmaceutical and biotechnology firms, as well as those focusing on cell and gene therapy development. The ValGenesis Smart GxPâ„¢ platform will be highlighted at this event.",
            "link": "https://www.markets.news/headlines/3016abb6-bb55-4ec2-a6a3-ca9e7e8909a5",
            "pub_date": "2026-02-28 02:05:53",
            "source": "unusualwhales",
            "kind": 1,
            "language": "en"
        },
        {
            "title": "ERLY Skincare reaches milestone of one year, fueled by loyal customers and grassroots support in Austin.",
            "id": "3b47bc06-acc8-4e1e-b6d7-11d5c7ff22ad",
            "description": "ERLY Skincare, an acclaimed brand headquartered in Austin, has reached a significant milestone year due to its loyal customer base, strong grassroots support, and the introduction of innovative initiatives. As of February 27, 2026, the company commemorates its one-year anniversary, demonstrating a year's worth of revolutionary progress in redefining skincare standards.",
            "link": "https://www.markets.news/headlines/3b47bc06-acc8-4e1e-b6d7-11d5c7ff22ad",
            "pub_date": "2026-02-28 01:56:26",
            "source": "unusualwhales",
            "kind": 1,
            "language": "en"
        },
        {
            "title": "BioArctic AB issued 78,000 Class B shares on Feb 27, 2026; total number of shares and votes.",
            "id": "68d70d43-6043-4d9c-8fa6-a17ad0cda265",
            "description": "Today, BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) revealed that they had distributed 78,000 Class B shares in February as part of the 2019/2028 stock option program approved at the Annual General Meeting in May.",
            "link": "https://www.markets.news/headlines/68d70d43-6043-4d9c-8fa6-a17ad0cda265",
            "pub_date": "2026-02-28 01:58:29",
            "source": "unusualwhales",
            "kind": 1,
            "language": "en"
        },
        {
            "title": "MARA stock rises 10% after $1.7B loss from Bitcoin writedowns; pivoting to AI infrastructure partnership. Q4 revenue down 6%.",
            "id": "8709a3a4-b4ac-4249-a647-52d93da575dc",
            "description": "MARA Holdings (NASDAQ: MARA) saw a remarkable 10% surge following the announcement of a partnership with Starwood Digital Ventures to convert mining sites for AI infrastructure. This surge comes in the wake of a Q4 loss of $1.7 billion due to Bitcoin (CRYPTO: BTC) writedowns. The $1.7 billion net loss for Q4 represents a significant drop from the $528.3 million net income reported a year earlier. A substantial decrease in the fair value of Bitcoin holdings by $1.5 billion negated any operating gains, coinciding with BTC's price drop from $114,068 at the end of Q3 to $87,498 by December 31. Revenue also took a hit in Q4, falling by 6% to $202.3 million from $214.4 million in Q4 2024, propelled by a 14% decline in the average price of Bitcoin mined during that period. Despite this, the full-year revenue experienced a notable 38% growth to $907.1 million. However, this positive full-year growth was overshadowed by the massive quarterly writedown. MARA currently holds 53,822 BTC with an estimated value of approximately $4.7 billion.",
            "link": "https://www.markets.news/headlines/8709a3a4-b4ac-4249-a647-52d93da575dc",
            "pub_date": "2026-02-28 01:58:35",
            "source": "unusualwhales",
            "kind": 1,
            "language": "en"
        },
        {
            "title": "",
            "id": "8a4d3a39-75a1-4daa-8575-219faa888f35",
            "description": "Trump on Iran: Additional talks today.",
            "link": "https://www.markets.news/headlines/8a4d3a39-75a1-4daa-8575-219faa888f35",
            "pub_date": "2026-02-28 01:59:39",
            "source": "unusualwhales",
            "kind": 1,
            "language": "en"
        },
        {
            "title": "",
            "id": "816530e9-eb51-4651-83bb-d210480503a5",
            "description": "TRUMP ON LUTNICK, EPSTEIN PROBE:HE'LL DO WHATEVER HE HAS TO SAY",
            "link": "https://www.markets.news/headlines/816530e9-eb51-4651-83bb-d210480503a5",
            "pub_date": "2026-02-28 02:00:43",
            "source": "unusualwhales",
            "kind": 1,
            "language": "en"
        }
    ]
}